Pictet Asset Management
CRMD icon

Pictet Asset Management’s CorMedix CRMD Stock Holding History

Pictet Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,430
Closed -$112K – 2158
2026
Q1 		$112K Hold
16,430
– – ﹤0.01% 2024
2025
Q4 		$191K Hold
16,430
– – ﹤0.01% 1933
2025
Q3 		$191K Buy
+16,430
New +$199K ﹤0.01% 1891
2025
Q2 		– Sell
-15,148
Closed -$93.3K – 2012
2025
Q1 		$93.3K Buy
+15,148
New +$157K ﹤0.01% 1938

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pictet Asset Management's CRMD Position: Q2 2026 in Review

Pictet Asset Management sold out of CorMedix (CRMD) in Q2 2026, closing a stake of 16,430 shares — an estimated $112K sold.

Pictet Asset Management first reported a position in CRMD in Q1 2025 and held it in 4 quarters. The position peaked at $191K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Pictet Asset Management reported no remaining CorMedix position as of Q2 2026 after selling out during the quarter.
  • Pictet Asset Management sold 16,430 CorMedix shares in Q2 2026, an estimated $112K.
  • Pictet Asset Management first reported a position in CorMedix in Q1 2025 and held it in 4 quarters.
  • Pictet Asset Management's CorMedix position peaked at $191K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.